Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.
Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Orthopaedics decided to stop selling all custom fitted devices in response to an FDA warning following an inspection of the Warsaw, Ind.-based company’s facilities.
Several additional Johnson & Johnson (NYSE:JNJ) executives were deposed for questioning in the ongoing lawsuits regarding subsidiary DePuy Orthopaedics’ ASR metal-on-metal implants.
Emerging markets are too complex for smaller firms to navigate and a foreign-focused startup may send the wrong signals to possible buyers, med-tech CEOs tell an audience at the AdvaMed OneMed conference in San Francisco.